Introduction

Inherited retinal diseases (IRDs) such as Best disease present unique diagnostic and management challenges. Recently, a groundbreaking study published in the Journal of Clinical Medicine explored an exceptionally rare clinical scenario: patients carrying pathogenic mutations in two distinct genes, BEST1 and EFEMP1, simultaneously. For patients, families, and researchers, understanding how multiple genetic variants interact can shed light on disease variability and pave the way for more precise diagnostic and therapeutic strategies.

Decoding Dual Genetic Diagnoses

Best disease is typically caused by mutations in the BEST1 gene, leading to the accumulation of lipofuscin in the retinal pigment epithelium (RPE) and the classic "egg-yolk" macular lesion. On the other hand, mutations in the EFEMP1 gene are associated with autosomal dominant drusen (ADD), characterized by the buildup of extracellular deposits beneath the RPE.

When both conditions overlap—referred to as Best disease and autosomal dominant drusen (BD-ADD)—clinicians observe a combination of features from both disorders. This study aimed to map the precise morphological and functional features of this dual diagnosis using cutting-edge imaging technologies and genetic analysis.

Key Findings from Multimodal Imaging

The researchers utilized advanced diagnostic tools, including fundus autofluorescence (FAF) imaging, spectral-domain optical coherence tomography (SD-OCT), and polarization-sensitive optical coherence tomography (PS-OCT), alongside targeted whole-exome sequencing.

Key observations included:

  • Thickened RPE Complex: SD-OCT imaging revealed a thickened RPE-Bruch's membrane complex corresponding to macular drusen-like deposits in both isolated ADD and dual-genotype BD-ADD patients.
  • Unique Autofluorescence Patterns: While both groups showed large hyperautofluorescent spots corresponding to sub-RPE drusen, the BD-ADD patients uniquely exhibited small hyperautofluorescent dots originating from hyperreflective photoreceptor debris located at or above the RPE.
  • Detailed Tissue Contrast: PS-OCT imaging provided exceptional tissue-specific contrast, allowing researchers to visualize structural changes in the subretinal material, identify the RPE within the macular lesion, and detect early signs of scar formation.

Implications for Treatment and Patient Care

Discovering that two independent autosomal dominant disorders can coexist and modify each other's phenotypic expression is a crucial step forward. For clinicians, recognizing dual-genotype presentations prevents misdiagnosis and ensures that families receive accurate genetic counseling regarding inheritance patterns and prognosis.

As targeted therapies—such as gene augmentation and advanced retinal protection strategies—continue to evolve, understanding complex genetic interactions ensures that future treatments can account for overlapping pathologies rather than single-gene targets alone.

Conclusion

The exploration of dual BEST1 and EFEMP1 mutations highlights the power of advanced multimodal imaging in dissecting complex retinal phenotypes. By bridging the gap between genetic profiles and structural tissue changes, research like this brings the scientific community closer to comprehensive, personalized care models for inherited macular degenerations.